trending Market Intelligence /marketintelligence/en/news-insights/trending/rCJv48839SluQ_-KPvmBAg2 content esgSubNav
In This List

Report: Sucampo Pharmaceuticals explores options, potential sale

Video

According to Market Intelligence, December 2022

Blog

Insight Weekly: Layoffs swell; energy efficiency PE deals defy downturn; 2023 global risk themes

Blog

Insight Weekly: Energy crisis cripples Europe; i-bank incomes rise; US holiday sales outlook

Blog

Japan M&A By the Numbers: Q3 2022


Report: Sucampo Pharmaceuticals explores options, potential sale

Sucampo Pharmaceuticals Inc. is assessing options — including putting the company up for sale — after it received takeover interest, Bloomberg News reported, citing people familiar with the matter.

Sucampo has not yet decided what it will do and may opt to seek growth through acquisitions instead, the sources noted.

The U.S. biopharmaceutical company could be attractive for large drugmakers interested in gastroenterology, which is Sucampo's focus, the insiders added.